Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus BWI Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus creativebharatgroup@gmail.com December 11, 2024 Canton, Mass., United States: Orthogon Therapeutics, a developer of novel antiviral medicines,... Read More Read more about Orthogon Therapeutics Closes Oversubscribed $5.2M Financing to Advance First Oral Therapy for BK Polyomavirus
